NHS gender clinic waiting lists now exceed 80 months in many parts of the UK, with some clinics projecting waits measured in decades rather than years. Private care is available but costs hundreds of pounds a month, putting it out of reach for many. DIY HRT has become a widespread survival response to a system that has effectively collapsed for most trans people seeking public provision. The crisis is deepening, and the banning of puberty blockers for trans young people has added forced detransition to the list of harms being caused by systemic failure.
What are the actual NHS waiting times right now?
People ask me whether there is any realistic way to access NHS gender care, and I find it increasingly hard to give them an honest answer that also offers hope. Because the honest answer is: not really, not for most people, and not soon.
When you look at the numbers, they stop reading like healthcare statistics and start reading like something else entirely. The Sandyford Clinic in Scotland has at points projected a wait of over 200 years for new referrals. Brackenburn has been quoted at around 41 years. The Laurels at around 31. These are not rounding errors or pessimistic projections. They are the arithmetic result of a referral rate that has outpaced the system's capacity so comprehensively that the system has, in any meaningful sense, stopped functioning as a healthcare pathway.
Across England, waits now routinely exceed 80 months, which is nearly seven years. A person referred today at 18 would be in their mid-twenties before they reached a first appointment. A child who needed support at 13 would be a young adult before anything happened. That is not a queue. That is a wall.
Who is left to provide this care?
There is another dimension to this that worries me as much as the raw numbers. The gender specialists who built their expertise over decades, the clinicians who understood this work and had the experience to do it well, are approaching retirement age. Has the NHS made provision for new specialists to replace them? Has there been training, recruitment, a plan to build capacity from the ground up? I have not seen it. I have not seen those waiting lists come down. What I have seen is a system in which expertise is ageing out while the number of people who need it keeps rising.
That combination, shrinking specialist capacity and growing demand, only resolves one way without deliberate structural intervention. The waits get longer. The care gets harder to access. And the people who cannot wait, which is most people, have to find another way.
Forced detransition: the hidden harm nobody is naming
The crisis has grown a new and particularly cruel face in recent years. Since the ban on puberty blockers for trans young people in the UK, a number of young people who were already on treatment have been forced to stop. Not because their care was assessed and found to be wrong for them. Not because their circumstances changed. Because the medication became legally unavailable on private prescription, and NHS provision was already essentially non-existent.
Forced detransition is what happens when a system removes access to care from someone who is already mid-way through a treatment pathway. The physical effects of puberty that the blockers were pausing resume. The psychological effects of that are serious, well-documented by people who have lived them, and almost entirely absent from the public conversation about why the ban was introduced. The ban was framed as precaution. For the young people who experienced it, it was harm.
And it sits alongside the broader reality that trans people are routinely being denied other healthcare, not just gender-specific care. People report being refused treatment for conditions entirely unrelated to their gender, or having their trans identity treated as the lens through which every other health concern is filtered. That is discrimination, and it compounds the harm of an already inadequate system.
What does private care actually cost?
The answer to NHS failure, for those who can afford it, is private care. An initial consultation with a gender specialist privately typically runs into several hundred pounds. Ongoing prescription costs, blood monitoring, and follow-up appointments add up. Many people I hear from are spending £200 to £400 a month, sometimes more, depending on where they are and what they need. For someone on a median UK income, that is a significant portion of their take-home pay. For someone on a low income, it is simply not possible.
Private care also requires knowing where to look, having the confidence to navigate unfamiliar systems, and often having a GP who will cooperate with a shared-care arrangement once a private specialist has made a prescription recommendation. That cooperation is not guaranteed. Some GPs refuse on grounds of unfamiliarity, discomfort, or explicit opposition to gender-affirming care. The result is that even people who can afford private consultation sometimes find themselves without anyone willing to actually dispense the prescription locally.
The system, in other words, has gaps inside its gaps.
Why DIY HRT has become a survival response
When the NHS cannot help you and private care is out of reach, and when you know precisely what you need and know that the medication itself is not unusual or dangerous when used correctly, some people decide to source it themselves. DIY HRT, meaning hormones obtained without a prescription and self-administered without medical supervision, has become widespread enough that it is now part of the lived reality of trans healthcare in the UK.
I am not going to pretend this carries no risks. It does. The specific risks are around monitoring: hormones affect the cardiovascular system, liver function, bone density, and other systems that benefit from periodic blood tests. Without regular monitoring, problems can go undetected. The medications themselves, when correctly identified and sourced from reliable suppliers, are typically the same bio-identical hormones used in prescribed care, but "typically" is doing a lot of work in a context without regulation or verification.
What I will not do is treat DIY HRT as a moral failing or a reckless choice made by people who do not understand the stakes. The people doing this almost always understand the stakes very well. They have usually spent months or years trying to access care through legitimate routes. They have read everything they can find. They are making a calculated decision that the risk of proceeding without monitoring is lower than the harm of continuing without any care at all. Given what the waiting lists look like, that calculation is not unreasonable.
The answer to DIY HRT is not to lecture people about its risks. It is to provide the care that makes it unnecessary.
What can you actually do right now?
If you are sitting on an NHS waiting list, or have just been referred and discovered the wait time, here is the realistic picture. The NHS pathway is unlikely to help you in any timeframe that resembles care. If you can afford private care, that is the most straightforward route to supervised, monitored, appropriate treatment. A private gender specialist can assess you, recommend treatment, and work with your GP on shared care. It is not perfect, but it is safer and faster than waiting.
If private care is not affordable, it is worth knowing that costs vary considerably between providers, and some operate on a more accessible fee structure than others. GenderGP at gendergp.com[1] is one option specifically designed to reach people the public waiting lists cannot serve. It is not free, but it is designed with accessibility in mind and uses current international standards for gender-affirming care.
If you are already on DIY HRT and cannot access supervised care, the single most useful thing you can do is get blood tests. Some GPs will run hormone panels on request without requiring a referral, and some private labs offer them directly. Knowing your levels and your liver and kidney function costs relatively little compared to the consequences of not knowing.
The system was not designed to fail like this
It would be easier, in some ways, if this were a simple story of bad intentions. But the collapse of NHS trans healthcare is the product of many things at once: inadequate planning for demand that has been rising for years, political hesitancy that slowed structural reform, a hostile public conversation that made investment politically uncomfortable, and a ban on puberty blockers that removed a generation of young people from the care they were already receiving.
The people who built the older gender clinics did important work. The clinicians still doing this work inside a broken system are doing it under extraordinary pressure. But the system they are working within has not been resourced, reformed, or rebuilt to match the need it faces. And in the absence of that, the harm falls on trans people, every day, in ways that are quiet, private, and largely invisible to anyone not living them.
I keep hearing from people who are tired. Tired of waiting, tired of being told the pathway exists when the pathway is a queue stretching further than any of them will live to reach. I do not have a solution that fixes the system from the outside. What I can say is that the situation is understood, it is not acceptable, and the people navigating it without adequate support are not failing. The system is failing them.
Comments